SEARCH

SEARCH BY CITATION

References

  • 1
    van Rie A, Warren R, Richardson M et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 11741179.
  • 2
    Geng E, Kreiswirth B, Driver C et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002; 346: 14531458.
  • 3
    von Pirquet C. Die Allergieprobe zur Diagnose der Tuberkulose im Kindesalter. Wien Med Wochenschr 1907; 57: 13701374.
  • 4
    Pai M. Session 9 guidelines; section: guidelines on IGRAs: concordant or discordant. Int J Tuberc Lung Dis [Symposium Supplement.] 2010; 14: S64S70.
  • 5
    Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection – United States, 2010. MMWR Recomm Rep 2010; 59 (RR-5): 125.
  • 6
    Pickering LK, Baker CJ, Kimberlin DW, Long SS. American Academy of Pediatrics. Tuberculosis. In: eds. Red Book: 2009 report of the committee on infectious diseases, 28th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2009; 680701.
  • 7
    Canadian Tuberculosis Committee. Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep (Releve des maladies transmissibles au Canada) 2010; 36 (ASC-5): 121.
  • 8
    National Institute for Health and Clinical Excellence. Clinical guideline 117. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: NICE, 2011; Available at: http://www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf (last accessed 24 March 2011).
  • 9
    Ministério da Saúde B. Manual de Recomendações para o Controle da Tuberculose no Brasil (Guidelines for the control of tuberculosis in Brazil). 2010. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/manual_de_recomendacoes_controle_tb_novo.pdf (last accessed 22 February 2011).
  • 10
    Bach-Nga P, Denis JD. Test de detection de la production d’interferon gamma pour le diagnostic des infections tuberculeuses (Interferon gamma tests for the diagnosis of tuberculosis infection). [Haute Autorite de Sante/Service évaluation des actes professionnels 2006; 1–50]. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_detection_de_linterferon-gamma.pdf.
  • 11
    Gonzalez-Martin J, Garcia-Garcia JM, Anibarro L et al. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Arch Bronconeumol 2010; 46: 255274.
  • 12
    Ministero della Salute de Italia. Aggiornamento della Raccomandazioni per le attivita di controllo della tuberculosi (update on the recommendations for the tuberculosis control activities). 2009. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1221_allegato.pdf (last accessed 22 February 2011).
  • 13
    Ministero della Salute. Aggiornamento della Raccomandazioni per le attivita di controllo della tuberculosi nella poplazione immigrata (update on the recommendations for the tuberculosis control activities in the immigrant population). 2010. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1261_allegato.pdf (last accessed 22 February 2011).
  • 14
    Diel R, Forssbohm M, Loytved G et al. Recommendations for background studies in tuberculosis. Pneumologie (Stuttgart, Germany) 2007; 61: 440455.
  • 15
    Diel R, Hauer B, Loddenkemper R, Manger B, Kruger K. Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases. Pneumologie (Stuttgart, Germany) 2009; 63: 329334.
  • 16
    Schmidgruber B. Guidelines for the diagnosis of latent tuberculosis in canton Vienna; personal communications with Beatrix Schmidgruber. 2011. Gesundheitsdiemst (Department of Public Health) of Vienna; Austria.
  • 17
    Ministerio da Saúde P. Tuberculose latente: projecto de expansão dos testes IGRA (Latent TB: Project for expansion of use of IGRAs). 2010. Available at: http://www.gnowee.net/content/guidelines/Portugal%20TB%20Testing%20Guidance%20Document%2011-FEB-2010.pdf (last accessed 22 February 2011).
  • 18
    National TB Advisory Committee. Guidelines on the prevention and control of tuberculosis in Ireland 2010. 2010. Available at: http://www.hpsc.ie/hpsc/A-Z/VaccinePreventable/TuberculosisTB/Publications/File,4349,en.pdf (last accessed 28 February 2011).
  • 19
    Swiss Lung Association. Handbuch tuberkulose (Handbook tuberculosis) – preliminary version. 2011. Available at: http://www.tbinfo.ch/de/publikationen/handbuch-tuberkulose.html (last accessed 19 February 2011).
  • 20
    van Altena R, Arend SM, Bossink A et al. RICHTLIJN, Interferon Gamma Release Assays bij de diagnostiek van tuberculose (Guidelines: interferon gamma release assays in the diagnosis of tuberculosis). 2011; available at: http://www.kncvtbc.nl (last accessed 8 May 2011).
  • 21
    Dansk Lungemedicinsk Selskab. Diagnostik af Tuberkulose (Diagnosis of tuberculosis). 2009. Available at: http://www.lungemedicin.dk/retningslinier/TB%20Diagnostik%20rev.pdf (last accessed 8 March 2011).
  • 22
    Norwegian Institute of Public Health. Tuberkuloseveilederen som e bok (Tuberculosis guide e-book). 2011. Available at: http://www.fhi.no/eway/default.aspx?pid=233&trg=MainArea_5661&MainArea_5661=6034:0:15,5092:1:0:0:::0:0 (last accessed 22 February 2011).
  • 23
    Ruutu P, Vasankari T, Rajalahti I et al. Suositus tuberkuloosin kontaktiselvityksen toteuttamiseksi (Finnish guidelines on tuberculosis control and contact investigations). 2011. Available at: http://www.thl.fi/thl-client/pdfs/7f089f81-1376-474b-ad99-8604e69f966c (last accessed 24 March 2011).
  • 24
    Czech Thoracic Society. Recommendation of Czech Thoracic Society for QuantiFERON-TB Gold test – personal communication with Ludek Trnka. 2005. Research Institute for Tuberculosis and Respiratory Diseases; Prague, Czech Republic.
  • 25
    Slovakian Ministry of Health. štandardizácii diagnostiky latentnej tuberkulóznej infekcie (Standards for the diagnosis of tuberculosis infection). 2010. Available at: http://www.health.gov.sk/swift_data/source/dokumenty/vestniky_mz_sr/2009/vestnik_12-18_2010.pdf (last accessed 22 February 2011).
  • 26
    Kucharz EJ, Korzeniewska-Koseła M, Kotulska A. Zalecenia postępowania w zapobieganiu i leczeniu gruźlicy u chorych leczonych antagonistami TNF-α (Recommendations for prophylaxis and management of tuberculosis in patients treated with TNF-α antagonists). Reumatologia 2008; 46: 5154.
  • 27
    Markova R. Guidelines for the diagnosis of latent tuberculosis in Bulgaria; personal communications with Roumiana Markova. 2011. Dept. Immunology and Allergology, National Centre of Infections and Parasitic Diseases; Sofia, Bulgaria.
  • 28
    Katalinic-Jankovic V. Guidelines for the diagnosis of latent tuberculosis in Croatia; personal communications with Vera Katalinic-Jankovic. 2011. Croatia National Institute of Public Health; Zagreb, Croatia.
  • 29
    Al Jahdali HH, Baharoon S, Abba AA et al. Saudi guidelines for testing and treatment of latent tuberculosis infection. Ann Saudi Med 2010; 30: 3849.
  • 30
    National Tuberculosis Advisory Committee Australia. Position statement on interferon-release immunoassays in the detection of latent tuberculosis infection. 2009. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-ntac-interferon.htm (last accessed 17 March 2011).
  • 31
    Murray RJ, Davis JS, Burgner DP et al. The Australasian Society for Infectious Diseases guidelines for the diagnosis, management and prevention of infections in recently arrived refugees: an abridged outline. Med J Aust 2009; 190: 421425.
  • 32
    Tymms K. Screening of latent tuberculosis infection (LTBI) prior to use of biological agents in Australia. 2010. Available at: http://www.rheumatology.org.au/downloads/April2010-Final-screeningforlatenttuberculosisinfection.pdf (last accessed 22 February 2011).
  • 33
    Shim TS. Draft of updated guidelines for the diagnosis of latent tuberculosis in South Korea; personal communications with Tae Sun Shim. 2011. University of Ulsan College of Medicine, Asan Medical Centre; Seoul, Korea.
  • 34
    Japanese Society for Tuberculosis Prevention Committee. Management of tuberculosis within medical facilities. Kekkaku 2010; 85: 477481.
  • 35
    World Health Organization. Strategic and Technical Advisory Group (STAG-TB). 2010. Report of the 10th Meeting. Available at: http://www.who.int/tb/advisory_bodies/stag_tb_report_2010.pdf (last accessed 22 February 2011).
  • 36
    World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf (last accessed 22 February 2011).
  • 37
    European Center for Disease Prevention and Control. Use of interferon-gamma release assays in support of TB diagnosis. Stockholm. 2011. Available at: http://ecdc.europa.eu/en/publications/Publications/1103_GUI_IGRA.pdf (last accessed 18 March 2011).
  • 38
    Metcalfe JZ, Everett C, Steingart KR et al. Interferon-gamma release assays for active pulmonary TB diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 2011. In press.
  • 39
    Sester M, Sotgiu G, Lange C et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011; 37: 100111.
  • 40
    Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis 2008; 8: 498510.
  • 41
    Ling DI, Pai M, Davids V et al. Are interferon-gamma release assays useful for active tuberculosis in a high-burden setting? Eur Respir J 2011; [Epub ahead of print].
  • 42
    Metcalfe JZ, Everett C, Steingart K et al. Interferon-gamma release assays for active pulmonary TB diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 2011; In press.
  • 43
    Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011; In press.
  • 44
    Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340354.
  • 45
    Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 2009; 15: 143155.
  • 46
    Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761776.
  • 47
    Bakir M, Millington KA, Soysal A et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008; 149: 777787.
  • 48
    del Corral H, Paris SC, Marin ND et al. IFN-gamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS ONE 2009; 4: e8257.
  • 49
    Hill PC, Jackson-Sillah DJ, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE 2008; 3: e1379.
  • 50
    Lienhardt C, Fielding K, Hane AA et al. Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS ONE 2010; 5: e10508.
  • 51
    Mahomed H, Hawkridge T, Verver S. The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS ONE 2011; Mar 29; 6(3): e17984.
  • 52
    Pai M. Spectrum of latent tuberculosis – existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010; 8: 242. Author reply.
  • 53
    Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 19201937.
  • 54
    Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M. Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis 2008; 12: 498505.
  • 55
    Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 2011; 8: e1001012.
  • 56
    van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-gamma assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 2009; 4: e8517.
  • 57
    Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011; [Epub ahead of print].
  • 58
    Markowitz N, Hansen NI, Hopewell PC et al. Incidence of tuberculosis in the United States among HIV-infected persons. The pulmonary complications of HIV Infection Study Group. Ann Intern Med 1997; 126: 123132.
  • 59
    Cattamanchi A, Smith R, Steingart KR et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011; 56: 230238.
  • 60
    Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 10981104.
  • 61
    Smith R, Cattamanchi A, Steingart KR, Denkinger C, Winthrop KL, Pai M. Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol 2011; [Epub ahead of print].
  • 62
    Winthrop KL. The risk and prevention of tuberculosis: screening strategies to detect latent tuberculosis among rheumatoid arthritis patients who use biologic therapy. Int J Adv Rheumatol 2010; 8: 4352.
  • 63
    Jasmer RM, Hahn JA, Small PM et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med 1999; 130: 971978.
  • 64
    Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2011; [Epub ahead of print].
  • 65
    Schunemann HJ, Oxman AD, Brozek J et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336: 11061110.
  • 66
    Gallardo CR, Rigau D, Irfan A et al. Quality of tuberculosis guidelines: urgent need for improvement. Int J Tuberc Lung Dis 2010; 14: 10451051.